Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Adult Kidney Transplant Recipients

BACKGROUND AND OBJECTIVES: Belatacept is a first-in-class, selective co-stimulation blocker recently approved for the prophylaxis of organ rejection in adult kidney transplant recipients. The objective of this study was to report the pharmacokinetics, pharmacodynamics, and immunogenicity of belatace...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shen, Jinshan, Townsend, Robert, You, Xiaoli, Shen, Yun, Zhan, Ping, Zhou, Zexun, Geng, Dong, Wu, Dianna, McGirr, Nadia, Soucek, Kathleen, Proszynski, Elizabeth, Pursley, Janice, Masson, Eric
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2013
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3899455/
https://ncbi.nlm.nih.gov/pubmed/24217983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-013-0153-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados